A Critical Review of Proteomic Studies in Gestational Diabetes Mellitus

Figure 1

Summary of the experimental designs applied in the reviewed studies. (a) Five pairs of disease-control design for GDM and its adverse effects; (b) eleven types of samples for proteomic analyses; (c) a summarized timetable of pregnancy trimesters (the whole pregnancy period is divided into three trimesters), pregnancy time (in months or weeks), birth terms (preterm or term birth), clinical events for GDM (diagnosis time or treatment time), potential research objectives of these proteomic studies (early prediction, precision diagnosis, or outcome prognosis), and sample types.

(a)

(b)

(c)